[The abnormality of immune status and its correction in patients with chronic pancreatitis].
The immune status has been studied at 44 patients with a chronic pancreatitis (CP). Control group consisting of healthy 36 persons. Infringements of the immune status are found out in patients CP and also a pressure humoral a component of immunity. Inclusion in the scheme of complex treatment patients of a CP immunomodulin (1.2-1.8 mg on a course of therapy) led to elimination of the expressed T-cellular immunodeficiency in its group and promoted restoration of some parameters humoral a component of immunity. Immunomodulin possessed medical and immunocorrection action at patients of a CP.
Suleĭmanov
S F
SF
D000328:Adult; D000917:Antibody Formation / Q000187:drug effects / Q000276:immunology*; D017074:Common Variable Immunodeficiency / Q000097:blood / Q000188:drug therapy / Q000276:immunology*; D005260:Female; D006801:Humans; D007111:Immunity, Cellular / Q000187:drug effects / Q000276:immunology; D008297:Male; D008875:Middle Aged; D009930:Organic Chemicals / Q000008:administration & dosage; D050500:Pancreatitis, Chronic / Q000097:blood / Q000188:drug therapy / Q000276:immunology*; D013601:T-Lymphocytes / Q000276:immunology*
D009930:Organic Chemicals; C404023:immunomodulin